GTM for MedTech

Outbound engineered like a system, not a spray-and-pray campaign.

Launch Builds runs cold email, LinkedIn outreach, and paid ads for medtech startups - backed by real research on every account, qualified before it reaches your calendar, and handed off into your CRM as a tracked opportunity.

Cold email LinkedIn outreach Paid ads Research-backed CRM-routed

Most GTM problems aren't a messaging problem. They're an infrastructure problem.

By the time outbound feels broken, the actual gap is usually a few steps upstream of the email itself.

01

Templates get deleted

If the first line could've been sent to any company in your category, it reads as spam before it's opened.

02

Reps research everything by hand

Hours go into understanding a single account before anyone writes a single line to them.

03

Signals get noticed and dropped

A hiring push or a funding round gets seen once and never turns into timed, relevant outreach.

04

Outbound and CRM don't talk

A qualified reply lands in an inbox, then someone has to manually turn it into a tracked opportunity, if they remember to.

05

Targeting is too broad

A big list burns a market once. The same accounts done wrong won't reply the second time either.

06

Reps chase low-fit accounts

Without scoring, time goes to whoever's easiest to find, not whoever's actually likely to buy.

A cold email agency sends messages. We build the process behind them first.

Before anything gets sent, we know who belongs on the list, what's actually true about them, and where a qualified reply goes once someone answers.

Without it

Outbound in isolation

A list gets bought, a sequence gets sent, replies land in an inbox someone has to manually sort. Nothing upstream or downstream is connected.

With it

Outbound as one step, not the whole plan

The list is built from your actual ICP, every account gets researched before a message is written, and a qualified reply routes into your CRM as a tracked opportunity.

The result

Repeatable, not one-off

The same process runs next quarter with the same accounts, refined by what actually got replies, not restarted from zero.

MedTech GTM breaks under a generic system.

The buyer, the cycle, and the purchasing process are different enough that a system built for typical B2B SaaS doesn't transfer cleanly.

The buyer

Technical, skeptical, and pitched constantly

Clinical and technical buyers can tell a templated message from the subject line. Generic outreach gets deleted before it's read.

The cycle

Long, and rarely one person's decision

Clinical, procurement, and IT stakeholders all weigh in before a health system signs anything. Outreach has to stay useful across quarters, not days.

The stakes

Institutional purchasing, high-value opportunities

Each qualified meeting represents a larger deal than typical SaaS outbound - exactly why the qualification criteria matter more here, not less.

Four stages. No black box.

01

Diagnose

We map your ICP, current GTM stack, sales process, and where the pipeline is actually breaking.

02

Architect

We design the system - which stages matter most for your buyer, what data sources make sense, which channels fit.

03

Build

We connect data, research, outreach, and CRM into one running system instead of six disconnected tools.

04

Optimize

We track what's converting and adjust targeting, messaging, and channel mix based on real replies, not guesses.

You don't pay us for activity.

No paying for emails sent, emails delivered, campaigns launched, or hours worked. You pay for qualified meetings - and "qualified" is defined before anything goes out, not after the fact.

  • Matches the ICP we agreed on upfront
  • The person is a relevant buyer, not just a reply
  • The problem we're raising is actually relevant to them
  • Geography and company criteria match what we agreed
  • They actually show up to the call
You pay forMeetings booked

Exact pricing depends on your ICP, deal size, and channel mix - confirmed on the call, not buried in fine print.

If it's not qualified, it's not billed. That's the mechanism, not a caveat.

  • We agree on exactly what "qualified" means before a single email goes out
  • A meeting that misses that bar doesn't go on your invoice, full stop
  • There's no minimum volume you're locked into buying either way

Full pricing detail and FAQ on the pricing page.

No MedTech case studies yet. Here's what we're relying on instead.

Launch Builds is purpose-built for MedTech, and new. The team behind it has previously built outbound and growth systems for companies in other industries, including a performance-based agency for allied health clinics. None of that is MedTech proof, and we're not going to pretend it is.

Independent advisor, gold strategy for federal banks

Chef, New York

Happiness coach, Canada

Prior client work, outside MedTech - shown here for transparency, not implied as MedTech proof.

01

The risk sits with us

The performance model means we don't get paid until the system actually produces a qualified meeting. That's a bigger commitment than a testimonial.

02

MedTech only

Not a vertical we dabble in alongside eleven others. Every account, every hour, goes toward understanding this specific buyer.

03

Nothing gets fabricated

If we can't find something real and specific about a prospect, we skip them. The same rule applies to how we talk about our own results.

B2B MedTech companies with an actual sales motion.

Not exploring outbound as an experiment. Selling into clinics, hospitals, or health systems, with a defined buyer and a real deal size behind each meeting.

MedTech startups B2B healthcare technology Medical device companies Clinical technology companies Healthcare software companies

The two-minute version, on video.

Video coming soon

Tell us where your outbound is actually breaking.

15 minutes to map your ICP, what you've tried so far, and whether this is a fit.

Map my GTM system